Mahesh Karande
2023
In 2023, Mahesh Karande earned a total compensation of $1.7M as President and Chief Executive Officer at Omega Therapeutics, a 56% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $320,320 |
|---|---|
| Option Awards | $765,340 |
| Salary | $578,667 |
| Other | $11,400 |
| Total | $1,675,727 |
Karande received $765.3K in option awards, accounting for 46% of the total pay in 2023.
Karande also received $320.3K in non-equity incentive plan, $578.7K in salary and $11.4K in other compensation.
Rankings
In 2023, Mahesh Karande's compensation ranked 676th out of 2,978 executives tracked by ExecPay. In other words, Karande earned more than 77.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 676 out of 2,978 | 77th |
Division Manufacturing | 382 out of 1,637 | 77th |
Major group Chemicals And Allied Products | 260 out of 906 | 71st |
Industry group Drugs | 256 out of 869 | 71st |
Industry Biological Products, Except Diagnostic Substances | 87 out of 211 | 59th |
Source: SEC filing on April 29, 2024.
Karande's colleagues
We found two more compensation records of executives who worked with Mahesh Karande at Omega Therapeutics in 2023.